Safety and Efficacy of Econazole Nitrate Foam 1% and Foam Vehicle in Subjects With Tinea Pedis

PHASE3CompletedINTERVENTIONAL
Enrollment

336

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

April 30, 2012

Study Completion Date

August 31, 2012

Conditions
Tinea PedisAthlete's Foot
Interventions
DRUG

Econazole Nitrate Foam 1%

Econazole Nitrate Foam 1% applied once a day for 4 weeks

DRUG

Vehicle Foam

Vehicle Foam applied once a day for 4 week

DRUG

Econazole Nitrate Cream 1%

Econazole Nitrate Foam 1% applied once a day for 4 weeks

OTHER

Placebo Cream

Placebo cream applied once a day for 4 weeks

Trial Locations (12)

19707

Guy F. Webster, MD, PhD, Hockessin

23507

David M. Pariser, MD, FAAD, FACP, Norfolk

32204

Jonathan Kantor, MD, Jacksonville

33486

Marta I. Rendon, MD, Boca Raton

37917

Edward J. Primka III, MD, Knoxville

53719

Harry H. Sharata, MD, PhD, Madison

55432

Steven E. Kempers, MD, Fridley

68144

Joel Schlessinger, MD, Omaha

75230

William Abramovits, MD, Dallas

78759

Michael T. Jarratt, MD, Austin

94538

Sunil S. Dhawan, MD, Fremont

97210

Phoebe Rich, MD, Portland

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

AmDerma Pharmaceuticals, LLC

INDUSTRY

lead

AmDerma

INDUSTRY

NCT01358240 - Safety and Efficacy of Econazole Nitrate Foam 1% and Foam Vehicle in Subjects With Tinea Pedis | Biotech Hunter | Biotech Hunter